Cargando…

Incidence of atazanavir- associated adverse drug reactions in second -line drugs treated south Indian HIV-1 infected patients

BACKGROUND: Ritonavir-boosted atazanavir (ATV/r) is the preferred second-line protease inhibitor (PI) option for HIV patients in resource-limited settings; its pattern of adverse drug reactions (ADRs) has not been much reported from India; hence, in this study, we have analyzed the incidence of ATV/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subashini, Dhakshinamoorthy, Dinesha, Thongadi Ramesh, Boobalan, Jayaseelan, Samuel, Lawrence Christopher, Poongulali, Selvamuthu, Pradeep, Ambrose, Solomon, Sunil Suhas, Solomon, Suniti, Balakrishnan, Pachamuthu, Saravanan, Shanmugam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051255/ https://www.ncbi.nlm.nih.gov/pubmed/27721547 http://dx.doi.org/10.4103/0253-7613.190759

Ejemplares similares

Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients
por: Subashini, Dhakshinamoorthy, et al.
Publicado: (2018)

Anti-HIV microRNA expression in a novel Indian cohort
por: Dey, Rakesh, et al.
Publicado: (2016)

The Evolution of Regulatory Elements in the Emerging Promoter-Variant Strains of HIV-1 Subtype C
por: Bhange, Disha, et al.
Publicado: (2021)

Expression of the human microRNA miR 29a in an Indian cohort of HIV patients
por: Dey, Rakesh, et al.
Publicado: (2014)

Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India
por: Solomon, Sunil S., et al.
Publicado: (2016)

Ertapenem for multiple β-lactamases producing Gram-negative bacteria causing urinary tract infections in HIV patients
por: Kumar, Marimuthu Ragavan Ramesh, et al.
Publicado: (2017)

Low-cost assays for monitoring HIV infected individuals in resource-limited settings
por: Balakrishnan, Pachamuthu, et al.
Publicado: (2011)

The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa
por: Sharma, Shilpee, et al.
Publicado: (2017)

Performance of urinalysis tests in screening for significant bacteriuria among human immunodeficiency virus-infected subjects in South India
por: Vignesh, Ramachandran, et al.
Publicado: (2017)

Elevated Numbers of HIV-Specific Poly-Functional CD8(+) T Cells With Stem Cell-Like and Follicular Homing Phenotypes in HIV-Exposed Seronegative Individuals
por: Munusamy Ponnan, Sivasankaran, et al.
Publicado: (2021)

Trimethoprim sulfamethoxazole drug resistance with co resistance to extended spectrum β-lactam antibiotics among bacterial isolates from HIV patients
por: Rameshkumar, Marimuthu Ragavan, et al.
Publicado: (2014)

A prospective analysis of viral immune escape in the chronic phase of the subtype C HIV-1 infections of India
por: Sharma, Shilpee, et al.
Publicado: (2012)

HIV serodiscordant relationships in India: Translating science to practice
por: Solomon, Sunil Suhas, et al.
Publicado: (2011)

Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women
por: Munusamy Ponnan, Sivasankaran, et al.
Publicado: (2021)

Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India
por: Kausalya, Bagavathi, et al.
Publicado: (2022)

Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease?
por: Shankar, Esaki Muthu, et al.
Publicado: (2008)

Longer sequence insertions in p6 gag play a role in immune escape in HIV-1 subtype C
por: Sharma, Shilpee, et al.
Publicado: (2014)

Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells
por: Pallikkuth, Suresh, et al.
Publicado: (2018)

Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India
por: Kumarasamy, Nagalingeswaran, et al.
Publicado: (2018)

Retrospective Analysis of Antibiotic Resistance in Streptococcus spp. from HIV Patients (2012–2017) from Southern India
por: Swathirajan, Chinnambedu Ravichandran, et al.
Publicado: (2019)

Bacterial etiology and antibiotic resistance profile of bloodstream infections in human immunodeficiency virus patients from Southern India
por: Swathirajan, Chinnambedu Ravichandran, et al.
Publicado: (2019)

Do the clonally different Escherichia coli isolates causing different infections in a HIV positive patient affect the selection of antibiotics for their treatment?
por: Rameshkumar, Marimuthu Ragavan, et al.
Publicado: (2018)

Therapeutic drug monitoring (TDM) of atazanavir in pregnancy
por: Else, LJ, et al.
Publicado: (2010)

Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm?
por: Vignesh, Ramachandran, et al.
Publicado: (2021)

Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India
por: Mehta, Shruti H., et al.
Publicado: (2010)

Detection of bla(NDM-1) and bla(NDM-5) genes among Gram-negative bacteria isolated from human immunodeficiency virus patients in South India
por: Rameshkumar, Marimuthu Ragavan, et al.
Publicado: (2018)

The Hidden Burden of Dengue and Chikungunya in Chennai, India
por: Rodríguez-Barraquer, Isabel, et al.
Publicado: (2015)

Atypically distributed cutaneous lesions of Norwegian scabies in an HIV-positive man in South India: a case report
por: Ramachandran, Vignesh, et al.
Publicado: (2008)

Impact of COVID-19 on people living with HIV: A review
por: Prabhu, Sandeep, et al.
Publicado: (2020)

Expansion of HIV Laboratory Diagnostic Services in Chennai, India 2001–2006: Is the Growth Commensurate with the Need?
por: Srikrishnan, A. K., et al.
Publicado: (2008)

Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: Views over hidden possibilities
por: Shankar, Esaki Muthu, et al.
Publicado: (2007)

Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir
por: Beckman, Joshua A., et al.
Publicado: (2017)

Drug‐drug interaction of atazanavir on UGT1A1‐mediated glucuronidation of molidustat in human
por: van der Mey, Dorina, et al.
Publicado: (2020)

Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
por: Montanha, Maiara Camotti, et al.
Publicado: (2021)

Atazanavir nephrotoxicity
por: Hara, Masaki, et al.
Publicado: (2015)

Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey
por: Belludi, Ashwin, et al.
Publicado: (2021)

Design of the Indian NCA study (Indian national collaboration on AIDS): a cluster randomized trial to evaluate the effectiveness of integrated care centers to improve HIV outcomes among men who have sex with men and persons who inject drugs in India
por: Solomon, Sunil S., et al.
Publicado: (2016)

HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India
por: Swathirajan, Chinnambedu Ravichandran, et al.
Publicado: (2018)

Antenatal Atazanavir: A Retrospective Analysis of Pregnancies Exposed to Atazanavir
por: Samuel, Miriam, et al.
Publicado: (2014)

Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
por: Montanha, Maiara Camotti, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_15p26vjjbkueeq8a2d3qor0eb8